iResearch Atlanta

Recent papers from iResearch Atlanta

1. Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 yearsHuman Vaccines & Immunotherapeutics · 2026
2. INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's diseaseThe Journal of Prevention of Alzheimer s Disease · 2025
3. Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)Menopause The Journal of The North American Menopause Society · 2024
4. Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label studyDiabetes Obesity and Metabolism · 2024
5. Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability StudyJournal of Child and Adolescent Psychopharmacology · 2023
6. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCTThe Journal of Clinical Endocrinology & Metabolism · 2023
7. Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of AgeNew England Journal of Medicine · 2022
8. Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled StudyNeuropsychopharmacology · 2016